scispace - formally typeset
J

Jeffrey Alan Dodge

Researcher at Eli Lilly and Company

Publications -  107
Citations -  3407

Jeffrey Alan Dodge is an academic researcher from Eli Lilly and Company. The author has contributed to research in topics: Estrogen receptor & Estrogen. The author has an hindex of 32, co-authored 107 publications receiving 3273 citations. Previous affiliations of Jeffrey Alan Dodge include Indiana University & University of Texas at Austin.

Papers
More filters
Journal ArticleDOI

Efficacious modification of the mitsunobu reaction for inversions of sterically hindered secondary alcohols

TL;DR: In this article, a modification of the Mitsunobu protocol for effecting stereochemical inversions of alcohols has been discovered in which use of p-nitrobenzoic acid as the nucleophilic partner results in significantly improved yields with relatively hindered substrates.
Journal ArticleDOI

Molecular determinants of tissue selectivity in estrogen receptor modulators

TL;DR: Structural differences between raloxifene and tamoxifen may influence the conformations of their respective receptor/ligand complexes, thereby affecting which estrogen-responsive genes are modulated in various tissues, indicating that differences in tissue selective actions among benzothiophene and triarylethylene estrogen receptor modulators can be ascribed to discrete ligand conformations.
Journal ArticleDOI

DNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex

TL;DR: It is shown that binding of intact heterodimer to DNA alters the receptor dynamics in regions remote from the DNA-binding domains (DBDs), including the coactivator binding surfaces of both co-receptors, and that the sequence of the DNA response element can determine these dynamics.
Journal ArticleDOI

Environmental estrogens: effects on cholesterol lowering and bone in the ovariectomized rat.

TL;DR: Representative non-steroidal estrogens, from common environmental sources such as plants, pesticides, surfactants, plastics, and animal health products, demonstrated an ability to lower serum cholesterol and prevent bone loss in an estrogen-dependent animal model, the ovariectomized rat.